Memorial Sloan Kettering Cancer Center: Retinoblastoma trials

The registry lists 11 Retinoblastoma studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 1 1Phase 2 5No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma PatientsRecruitingNCT03546387
• Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerCompletedNCT00445965Phase 2Results posted
• Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsCompletedNCT00024258Phase 2Results posted
• 131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young AdultsNo longer availableNCT05064306
• Determining Whether Intra-Arterial Carboplatin Causes Hearing Loss in ChildrenCompletedNCT03866460
• Retinoblastoma Survivor Study: Assessment of General Health and Quality of LifeActive, not recruitingNCT00639301
• Research on the Environment and Children's Health: RetinoblastomaCompletedNCT00582049
• High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid TumorsCompletedNCT00003173Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerCompletedNCT00003022Phase 1
• Chemotherapy in Treating Patients With RetinoblastomaCompletedNCT00002675Phase 2
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare CancerCompletedNCT00002515Phase 2